Corrigendum to "Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors α and β [J. Steroid Biochem. Mol. Biol. 88 (2004) 53-59]" (DOI:10.1016/j.jsbmb.2003.10.006);Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors α and β

Journal of Steroid Biochemistry and Molecular Biology

Volumn 88, Issue 1, 2004, Pages 53-59

  Fujimoto, Nariaki ^a   Honda, Hiroaki ^a   Kitamura, Shigeyuki ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Ap1 mediated estrogen responses; Endocrine disruptors; Environmental estrogens; Estrogen receptors

Indexed keywords

CHLORPHENOTANE; ENVIRONMENTAL CHEMICAL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL; CONTROLLED STUDY; EMBRYO; ENVIRONMENTAL MONITORING; ESTROGEN RESPONSIVE ELEMENT; FIBROBLAST; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; SCREENING;

EID: 1542299148     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.03.002     Document Type: Erratum

References (24)

1. Colborn T., Vom S.F., Soto A.M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101:1993;378-384.
2. Krishnan V., Safe S. Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol. Appl. Pharmacol. 120:1993;55-61.
3. Baker V.A. Endocrine disrupters-testing strategies to assess human hazard. Toxicol. In Vitro. 15:2001;413-419.
4. Rhomberg L. Beyond screening: problems and prospects for risk characterization of endocrine disruptors. Regul. Toxicol. Pharmacol. 26:1997;74-79.
5. Hyder S.M., Shipley G.L., Stancel G.M. Estrogen action in target cells: selective requirements for activation of different hormone response elements. Mol. Cell Endocrinol. 112:1995;35-43.
6. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69:1999;3-12.
7. Gaub M.P., Bellard M., Scheuer I., Chambon P., Sassone C.P. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell. 63:1990;1267-1276.
8. Philips A., Chalbos D., Rochefort H. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF-7 breast cancer cells without affecting c-fos and c-jun synthesis published. J. Biol. Chem. 268:1993;14103-14108.
9. Umayahara Y., Kawamori R., Watada H., Imano E., Iwama N., Morishima T., Yamasaki Y., Kajimoto Y., Kamada T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP1 enhancer. J. Biol. Chem. 269:1994;16433-16442.
10. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol. Endocrinol. 9:1995;443-456.
11. Webb P., Nguyen P., Valentine C., Lopez G.N., Kwok G.R., McInerney E., Katzenellenbogen B.S., Enmark E., Gustafsson J.A., Nilsson S., Kushner P.J. The estrogen receptor enhances AP1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol. 13:1999;1672-1685.
12. Maruyama S., Fujimoto N., Asano K., Ito A. Suppression by estrogen receptor beta of AP1 mediated transactivation through estrogen receptor alpha. J. Steroid Biochem. Mol. Biol. 78:2001;177-184.
13. Baker V.A., Hepburn P.A., Kennedy S.J., Jones P.A., Lea L.J., Sumpter J.P., Ashby J. Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays. Food Chem. Toxicol. 37:1999;13-22.
14. Chen C.W., Hurd C., Vorojeikina D.P., Arnold S.F., Notides A.C. Transcriptional activation of the human estrogen receptor by DDT isomers and metabolites in yeast and MCF-7 cells. Biochem. Pharmacol. 53:1997;1161-1172.
15. Fujimoto N., Maruyama S., Ito A. Establishment of an estrogen responsive rat pituitary cell sub-line MtT/E-2. Endocr. J. 46:1999;389-396.
16. Maruyama S., Fujimoto N., Yin H., Ito A. Growth stimulation of a rat pituitary cell line MtT/E-2 by environmental estrogens in vitro and in vivo. Endocr. J. 46:1999;513-520.
17. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., Serrano F.O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103(Suppl. 7):1995;113-122.
18. Edmunds J.S., Fairey E.R., Ramsdell J.S. A rapid and sensitive high throughput reporter gene assay for estrogenic effects of environmental contaminants. Neurotoxicology. 18:1997;525-532.
19. Gaido K.W., Leonard L.S., Lovell S., Gould J.C., Babai D., Portier C.J., McDonnell D.P. Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143:1997;205-212.
20. Biegel L., Safe S. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34, 52, and 160. kDa proteins in human breast cancer cells J. Steroid Biochem. Mol. Biol. 37:1990;725-732.
21. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science. 277:1997;1508-1510.
22. Maruyama S., Fujimoto N., Asano K., Ito A. Suppression by estrogen receptor beta of AP1 mediated transactivation through estrogen receptor alpha. J. Steroid Biochem. Mol. Biol. 78:2001;177-184.
23. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:1997;863-870.
24. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Rolland R., Scott G., Sheehan D.M., Sinks T., Tilson H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the US EPA-sponsored workshop. Environ. Health Perspect. 104:1996;4715-4740.